Greenlane Holdings, Inc. (NASDAQ: GNLN)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Greenlane Holdings, Inc. (NASDAQ: GNLN) in connection with the company s proposed merger with KushCo Holdings, Inc. ( KushCo ). Under the terms of the agreement, KushCo s shareholders will receive approximately 0.2546 shares of GNLN Class A common stock for each KushCo share they own. If you own GNLN shares and wish to discuss this investigation or your rights, please call us or visit our website: http://www.weisslawllp.com/gnln/
PRA Health Sciences Inc. (NASDAQ: PRAH)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
NEW YORK, May 3, 2021 /PRNewswire/ Â Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PRA Health Sciences, Inc. (NASDAQ: PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to ICON plc. Under the terms of the transaction, PRA Health shareholders will receive $80.00 in cash and 0.4125 shares of ICON stock for each PRA Health share that they own.
- Advertisement -
Tribune Publishing Company (NASDAQ: TPCO) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of Alden Global Capital. Under the terms of the agreement, Alden will acquire all of the outstanding shares of Tribune common stock not currently owned by Alden for $17.25 per share in cash.Â
Baron Funds on ICON Public Ltd Co. (ICLR): “We See Significant Upside in the Stock Price”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 0.58% was delivered by the fund’s institutional shares for the Q1 of 2021, below both its S&P 500 and Russell 3000 Health Care benchmarks that delivered a 6.17% and 2.14% returns respectively for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Baron Health Care Fund, in their Q1 2021 investor letter, mentioned ICON Public Limited Company (NASDAQ: ICLR), and shared their insights on the company. ICON Public Limited Company is a Dublin, Ireland-based medical device company that currently has an $11.3 billion market capitalization. Since the beginning of the year, ICLR delivered a 9.63% return, extending its 12-month gains to 38.66%. As of April 29, 2021, the stock cl
ShockWave Medical, Inc. (NASDAQ: SWAV)
Verastem, Inc. (NASDAQ: VSTM)
Down In The Dumps
Akoya Biosciences, Inc. (NASDAQ: AKYA)
Decibel Therapeutics, Inc. (NASDAQ: DBTX)
IRadimed Corporation (NASDAQ: IRMD)
Lucira Health, Inc. (NASDAQ: LHDX)
Mesoblast Limited (NASDAQ: MESO)
Protara Therapeutics, Inc. (NASDAQ: TARA)
PTC Therapeutics, Inc. (NASDAQ: PTCT)
Stocks In Focus
Adverum Shares Sink On Serious Adverse Event
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
This event occurred 30 weeks after randomization in one patient treated with a single intravitreal injection of the high dose of ADVM-022 who has developed hypotony, with panuveitis and loss of vision in the treated eye.
USANA Health Sciences Raises FY Outlook
WASHINGTON (dpa-AFX) - USANA Health Sciences Inc. (USNA) said it increased its outlook for 2021, which now reflects top-line growth between 9.3% and 12.8%. Notably, it expects sales to accelerate during the second quarter, due largely to a short-term sales program it is offering around the world during the quarter.
The company offered a similar short-term sales program during the third quarter of 2020, which was successful and received a positive response from Associates around the world. Following the conclusion of the program, the company expects to see year-over-year sales growth, albeit at a decreased growth rate from the second quarter of this year.